Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Heterocyclic carbon compounds containing a hetero ring...
Reexamination Certificate
2011-03-15
2011-03-15
Habte, Kahsay T (Department: 1624)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Heterocyclic carbon compounds containing a hetero ring...
C544S105000
Reexamination Certificate
active
07906508
ABSTRACT:
A 3,4-dihydrobenzoxazine compound of the present invention is represented by the following formula [1] (wherein X is a nitrogen atom or CR3; R1is a hydrogen atom or a halogen atom; R2is a C1-6 alkoxy group which may be substituted with the same or different 1 to 5 substituents selected from a halogen atom and a hydroxyl group; and R3is a halogen atom. However, R1is a halogen atom when X is CR3). This compound is effective in treating diseases to which the vanilloid receptor subtype 1 (VR1) activity is involved, such as pain, etc.
REFERENCES:
patent: 1893091 (1933-01-01), Laska et al.
patent: 3678094 (1972-07-01), Shen et al.
patent: 3773936 (1973-11-01), Shen et al.
patent: 4640916 (1987-02-01), Meguro et al.
patent: 5712298 (1998-01-01), Amschler
patent: 5998400 (1999-12-01), Brieaddy et al.
patent: 6239267 (2001-05-01), Duckworth et al.
patent: 6268387 (2001-07-01), Connor et al.
patent: 6495555 (2002-12-01), Kennis et al.
patent: 6528528 (2003-03-01), Connor et al.
patent: 6624184 (2003-09-01), Gu et al.
patent: 6723730 (2004-04-01), Bakthavatchalam et al.
patent: 6933311 (2005-08-01), Lee et al.
patent: 7067507 (2006-06-01), Pulley et al.
patent: 7067553 (2006-06-01), Suh et al.
patent: 7074805 (2006-07-01), Lee et al.
patent: 7335678 (2008-02-01), Lee et al.
patent: 2001/0047090 (2001-11-01), Duckworth et al.
patent: 2003/0153596 (2003-08-01), Suh et al.
patent: 2003/0158188 (2003-08-01), Lee et al.
patent: 2003/0158198 (2003-08-01), Lee et al.
patent: 2003/0195201 (2003-10-01), Bo et al.
patent: 2003/0212140 (2003-11-01), Suh et al.
patent: 2003/0236280 (2003-12-01), Codd et al.
patent: 2004/0038969 (2004-02-01), Doherty et al.
patent: 2004/0044003 (2004-03-01), Kyle et al.
patent: 2004/0082562 (2004-04-01), Gu et al.
patent: 2004/0082780 (2004-04-01), Doherty et al.
patent: 2004/0102497 (2004-05-01), Gu et al.
patent: 2004/0122089 (2004-06-01), Martin et al.
patent: 2004/0138252 (2004-07-01), Ikeda et al.
patent: 2004/0142958 (2004-07-01), Herzberg et al.
patent: 2004/0157849 (2004-08-01), Lee et al.
patent: 2004/0176443 (2004-09-01), Bakthavatchalam et al.
patent: 2004/0209884 (2004-10-01), Lee et al.
patent: 2005/0004133 (2005-01-01), Makings et al.
patent: 2005/0107388 (2005-05-01), Brown et al.
patent: 2005/0158827 (2005-07-01), Curtis
patent: 2005/0165046 (2005-07-01), Hulme et al.
patent: 2005/0165049 (2005-07-01), Hulme et al.
patent: 2005/0176726 (2005-08-01), Wang et al.
patent: 2005/0182067 (2005-08-01), Balan et al.
patent: 2005/0227986 (2005-10-01), Bo et al.
patent: 2005/0267163 (2005-12-01), Doherty et al.
patent: 2005/0272777 (2005-12-01), Doherty et al.
patent: 2005/0272931 (2005-12-01), Bo et al.
patent: 2005/0277631 (2005-12-01), Doherty et al.
patent: 2005/0277646 (2005-12-01), Doherty et al.
patent: 2006/0030618 (2006-02-01), Bo et al.
patent: 2006/0035882 (2006-02-01), Koga et al.
patent: 2006/0035939 (2006-02-01), Koga et al.
patent: 2006/0100202 (2006-05-01), Raimi et al.
patent: 2006/0142333 (2006-06-01), MacDonald et al.
patent: 2007/0149517 (2007-06-01), Koga et al.
patent: 2008/0064687 (2008-03-01), Suh et al.
patent: 2008/0214524 (2008-09-01), Lee et al.
patent: 2009/0105298 (2009-04-01), Ikeda et al.
patent: 2 571 133 (2006-01-01), None
patent: 1006382 (1990-01-01), None
patent: 1126468 (1996-07-01), None
patent: 1059674 (2000-12-01), None
patent: 1335845 (2002-02-01), None
patent: 57141456 (1982-09-01), None
patent: 09-059236 (1997-03-01), None
patent: 2001-526255 (2001-12-01), None
patent: 2004-506714 (2003-03-01), None
patent: 2003-192673 (2003-07-01), None
patent: 2005-516951 (2005-06-01), None
patent: 2005-518371 (2005-06-01), None
patent: WO 97/48697 (1997-12-01), None
patent: WO 99/32433 (1999-07-01), None
patent: WO 00/020421 (2000-04-01), None
patent: WO 00/26197 (2000-05-01), None
patent: WO 00/29577 (2000-05-01), None
patent: WO 00/32766 (2000-06-01), None
patent: WO 00-040580 (2000-07-01), None
patent: WO 00/63415 (2000-10-01), None
patent: WO 02/08221 (2002-01-01), None
patent: WO 02/16318 (2002-02-01), None
patent: WO 02/064545 (2002-08-01), None
patent: WO 02/074726 (2002-09-01), None
patent: WO 03/006019 (2003-01-01), None
patent: WO 03/049702 (2003-06-01), None
patent: WO 03/053945 (2003-07-01), None
patent: WO 03/066593 (2003-08-01), None
patent: WO 03/068749 (2003-08-01), None
patent: WO 03/070247 (2003-08-01), None
patent: WO 03/080578 (2003-10-01), None
patent: WO 03/097586 (2003-11-01), None
patent: WO 03/099284 (2003-12-01), None
patent: WO 2004/009552 (2004-01-01), None
patent: WO 2004/022002 (2004-03-01), None
patent: WO 2004-052846 (2004-06-01), None
patent: WO 2004/054582 (2004-07-01), None
patent: WO 2004/056394 (2004-07-01), None
patent: WO 2004-056774 (2004-07-01), None
patent: WO 2004/108133 (2004-12-01), None
patent: WO 2005/023807 (2005-03-01), None
patent: WO 2005/070885 (2005-08-01), None
patent: WO 2005/077938 (2005-08-01), None
patent: WO 2005/077944 (2005-08-01), None
patent: WO 2005/103018 (2005-11-01), None
patent: WO 2006/006741 (2006-01-01), None
Bevan et al.,TINS, 17(12): 509-512 (1994).
Birder et al.,Nature Neuroscience, 5(9): 856-860 (2002).
Carlton et al,Neuroscience Letters, 310: 53-56 (2001).
Caterina et al.,Nature, 389: 816-824 (1997).
Caterina et al.,Science, 288: 306-313 (2000).
Chuang et al.,Nature, 411: 957-962 (2001).
Davis et al.,Nature, 405: 183-187 (2000).
Ikeda et al.,Life Sciences, 69: 2911-2919 (2001).
Numazaki et al.,Biochemistry, 75: 359-371 (2003).
Premkumar et al.,J. Physiol., 545(1): 107-117 (2002).
Purandare et al.,Tetrahedron Letters, 43: 3903-3906 (2002).
Shu et al.,Neuroscience Letters, 274: 159-162 (1999).
Sugiura et al.,J. Neurophysiol., 88: 544-548 (2002).
Szallasi et al.,Pharmacological Reviews, 51(2): 159-211 (1999).
Tominaga et al.,PNAS, 98(12): 6951-6956 (2001).
Yang et al.,J. Neurosci., 22(15): 6388-6393 (2002).
Yiangou et al.,The Lancet, 357: 1338-1339 (2001).
Correll et al.,Expert Opinion on Therapeutic Patents, 16(6): 783-95 (2006).
Planells-Cases et al.,Expert Opinion on Drug Discovery, 2(8): 1053-63 (2007).
“Post-Operative Pain,” http://www.painmd.com/types-of-pain/general-pain/postoperative-pain.html, accessed Jan. 4, 2010.
U.S. Appl. No. 11/181,235, Office Action dated Dec. 19, 2007.
U.S. Appl. No. 11/181,235, Reply to Office Action dated Jun. 13, 2008.
U.S. Appl. No. 11/181,235, Office Action dated Jun. 20, 2008.
U.S. Appl. No. 11/181,235, Reply to Office Action dated Sep. 9, 2008.
U.S. Appl. No. 11/181,235, Office Action dated Oct. 7, 2008.
U.S. Appl. No. 11/181,235, Reply to Office Action dated Jan. 7, 2009.
U.S. Appl. No. 11/183,265, Office Action dated Oct. 4, 2007.
U.S. Appl. No. 11/183,265, Reply to Office Action dated Nov. 2, 2007.
U.S. Appl. No. 11/183,265, Office Action dated Dec. 18, 2007.
U.S. Appl. No. 11/183,265, Reply to Office Action dated Apr. 9, 2008.
U.S. Appl. No. 11/183,265, Office Action dated Jul. 22, 2008.
U.S. Appl. No. 11/183,265, Office Action dated Sep. 29, 2008.
U.S. Appl. No. 11/183,265, Reply to Office Action dated Dec. 29, 2008.
U.S. Appl. No. 11/183,265, Office Action dated Apr. 1, 2009.
U.S. Appl. No. 11/183,265, Reply to Office Action dated Jul. 1, 2009.
U.S. Appl. No. 11/183,265, Advisory Action dated Aug. 4, 2009.
U.S. Appl. No. 11/183,265, Notice of Appeal dated Oct. 1, 2009.
U.S. Appl. No. 11/183,265, Pre-Appeal Brief Request for Review dated Oct. 1, 2009.
U.S. Appl. No. 11/183,265, Notice of Panel Decision dated Jan. 15, 2010.
U.S. Appl. No. 11/183,265, Office Action dated Jan. 28, 2010.
U.S. Appl. No. 11/183,265, Reply to Office Action dated Jun. 28, 2010.
U.S. Appl. No. 12/430,268, Office Action dated Mar. 30, 2010.
U.S. Appl. No. 12/430,268, Reply to Office Action dated Jun. 30, 2010.
Mashkovsky, M.D.,Medicaments, vol. 1, p. 11 (2001), English Translation of RU Office Action.
U.S. Appl. No. 11/183,265, Office Action dated Sep. 17, 2010.
U.S. Appl. No. 12/430,268, Office Action dated Aug. 19, 2010.
Hori Yoshikazu
Koga Yoshihisa
Kondo Wataru
Matsumoto Tatsuya
Sakata Masahiro
Habte Kahsay T
Japan Tobacco Inc.
Leydig , Voit & Mayer, Ltd.
LandOfFree
3,4-dihydrobenzoxazine compounds and inhibitors of vanilloid... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with 3,4-dihydrobenzoxazine compounds and inhibitors of vanilloid..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and 3,4-dihydrobenzoxazine compounds and inhibitors of vanilloid... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2699878